Hello, we are pleased to welcome all MACQWERTY investors. We are excited to share the latest updates on the future of the American bio-industry.

First of all, MACQWERTY has confirmed that the U.S. biotech industry is rapidly evolving. Innovations are taking place in areas that seemed possible only in science fiction, such as aging research, personalized medicine, and AI-based disease diagnosis and treatment. In this environment, MACQWERTY has integrated the bio-industry into its main portfolio and has achieved a return rate of 158% compared to the previous year.

In particular, the increased sales of biosimilars like iCis and Bio Marine significantly boosted MACQWERTY's profitability in 2020. MACQWERTY's 'Biosector Invest Healthcare MCT 1 Cooperative' is one of our proud major portfolios, which consistently shows good performance.

In 2022, our concentrated investments in Moderna, Amgen, and Gilead Sciences also brought good news to MACQWERTY investors. We would like to define MACQWERTY's execution of the life sciences portfolio as the 'clearest future growth in sector investing'. Of course, in 2023, new markets will grow, values will rise, and new sectors like energy and electric cars will be born, but we dare to say that this was the most valuable selection strategy among MACQWERTY's investment execution sectors in 2022. MACQWERTY will strive for a successful portfolio execution strategy in 2023.

However, the future bio-industry also faces many challenges. Investments in research and development are increasing, but it takes a considerable amount of time to see their effects. Also, privacy protection, ethical issues, and regulations on new therapies remain major challenges.

To solve these challenges, MACQWERTY not only invests in the bio-industry but also focuses on bonds that help the development of this industry. Through this, MACQWERTY aims to support the growth of the bio-industry and provide more stable returns to our investors.

The future of the U.S. bio-industry holds many unknowns, but MACQWERTY will not stop its efforts towards this future. The growth of this industry plays an important role in creating a better world, and MACQWERTY intends to lead this process.

We have faith in the future of the U.S. bio-industry and an investment strategy to support it. Through these efforts, we aim to support the future of our investors. We thank all investors who have chosen MACQWERTY.

MACQWERTY supports companies in the bio-industry sector to develop innovative products and services and to make a positive impact on society. We also assist these companies in raising the necessary funds to compete in the global market.

The future of the U.S. bio-industry is brighter than ever. With research and development, investment, and technology advancements going hand in hand, the bio-industry plays a crucial role in changing our lives. MACQWERTY is committed to supporting this growth in the bio-industry and aims to provide our investors with the best opportunities to maximize these opportunities.

We are confident that our investment strategy will contribute to increasing your assets and also support the growth of the bio-industry. We thank all investors who have chosen MACQWERTY once again and will do our best in our journey towards the future together. Thank you.